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Summary: Arginase from normal human mixed saliva was characterized. The enzyme was completely
activated after a preincubation of 20min at 55 °C and a Mn2+ final concentration of 5 mmol/1. The pH
Optimum was 9.6-9.8, and the Km for L-arginine was 4.2 ± 0.7 mmol/1. In normal saliva only one form
was found, which was chromatographically identical with the cationic form of arginase in liver and blood
cells. Salivary arginase was completely precipitated by rabbit aiitiserüm against human liver arginase.
Arginäse activity was not detectable in the saliva of patients suffering from argininaemia. Enzyme activities
in the saliva of the heterozygous parents and the unaffected daughter were 0.08, 0.07 and 0.12 U/mg protein,
respectively, whereas the activities in the saliva of 60 healthy adults and 8 children were 0.17 + 0.11 and
0.16 ± 0.06 U/mg protein, respectively.
Menschliche Speichel·Arginase und ihr Fehlen bei der Argininämie
Zusammenfassung: Die aus gemischtem Speichel gewonnene Arginase wurde charakterisiert. Nach Präinkuba-
tion von 20 min bei 55 °C und einer Mn*~ Endkonzentration von 5 mmol/1 wird das Enzym voll aktiviert.
Das pH-Optimum lag zwischen 9,6—9,8; der Äm-Wert für Arginin betrug 4,2 + 0,7 mmol/1. Im normalen
Speichel konnte nur eine Form der Arginase gefunden werden. Diese ist chromatographisch identisch mit der
kationischen Form der Lebere und Erythrocytenarginäse. Die Speichelarginase wird durch gegen menschliche
Leberarginase gerichtetes Kaninchenserum vollständig prä_zipitiert.
Im Speichel von Patienten mit Argininämie konnte keine Arginaseaktivität nachgewiesen werden. Die
Enzymaktivität im Speichel der heterozygoten Eltern betrug 0,08 resp. 0,07, diejenige der gesunden Schwester
0,12 U/mg Protein. Im Speichel von 60 gesunden Erwachsenen fand sich eine Aktivität von 0,17 ± 0,11, bei
8 Kindern eine solche von 0,16 ± 0,06* U/mg Protein.
Introduction erythrocytes (2-4) and leukocytes (5). In this paper
Argininaemia is an inborn metabolic disorder of the we report deficient arginase activity in the saliva of
urea cycle dtie to arginase (L-arginine- homozygous patients, together with our fmdings on
amidinohydrolase, EC 3.5.3.1) deficiency. The en- the properties of arginase from normal human saliva.
zyme deficiency has been demonsträted in liver (1), Kinetic, Chromatographie and immunological
' Presented in part at the 3rd International Symposium on similarities of salivary, hepatic and blood cell
Inborn Errors in Humans, Munich 1984. arginases suggest that they are genetically identical.
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Materials and Methods
Sumpling and preparation ofsaliva
Saliva was sampled from 60 healthy adults, aged 18 — 65 years,
8 healthy children, aged l to 4 years, and from three siblings
with argininaemia (6), their heterozygous parents and healthy
sister. Two individual samples at intervals of an hour were
obtained from each patient. Specimens of mixed saliva were
taken during unstimulated secretion foliowing prior rinsing of
the oral cavity. They were centrifuged at 1200# for 5 min and
the supernatant used for enzyme determinations.
Before the arginase assay, salivary mucus was dispersed by
sonication at 0 °C (2 χ 20s, 40 W, Sonifier BI2, Branson Sonic
Power Company, USA) or emulsified by homogenization in a
Teflonglass Potter type homogenizer for l min at 2000 min"1.
For Chromatographie and immunological procedures, saliva
was homogenized with 2-mercaptoethanol in a final con-
centration of 0.2 mol/1, and incubated at 0 °C for 2 hours in
Order to lower mucus viscosity (7). Any precipitate was then
removed by centrifugation and the supernatant was used for
further investigation.
Arginase assay
Arginase activity was measured by the amount of ornithine
liberated from L-arginine s Substrate. Ornithine was deter-
mined by the method of Chinard (8).
For the arginase assay, saliva from healthy subjects was diluted
5-fold. The reaction mixture (0.5 ml) contained 0.5 μπιοί of
MnCl2, 10 μπιοί of arginine and 30 μηιοί of carbonate buffer,
all adjusted to pH 9.8, and 0.05 ml of enzyme preparation.
After incubation at 37 °C for 15 min, the reaction was stopped
with 1.5ml of concentrated acetic acid, then 0.5ml of ninhydrin
solution was added (2.5g of ninhydrin in a mixture of 40ml of
6 mol/1 H3PO4 and 60 ml of glacial acetic acid). After heating
in-a boiling water bath for l hour the mixture was cooled and
the absorbance was read at 515 nm against a reagent blank. A
zero time blank was performed for each individual specimen
of saliva.
To measure fully Mn2+-activated arginase, the mixtures con-
taining 0.05 ml of enzyme preparation and 0.05 ml (0.5 μπιοί)
of MnCl2 were preincubated at 55 °C for 20 min. After cooling,
arginine and carbonate buffer were added, and the procedure
was performed s described above. Arginase in erythrocytes
was determined s described previously (9).
Arginase activity was expressed in units per mg of protein. One
unit of arginase is defmed s the amount of enzyme that
produces l μπιοί of ornithine per minute at 37 °C.
Protein was measured according to Lowry et al. (10) with
cristalline bovine serum albumin s a Standard.
Ιοη-exchange chromatography
For chromatography on DEAE- or CM-cellulose, saliva was
homogenized and incubated with 2-mercaptoethanol and then
dialysed overnight against 5 mmol/l MnCl2 in 5 mmol/1 Tris-
HC1 buffer, pH 8.3 or 7.5 respectively. Any precipitate was
removed by centrifugation and the supernatant was applied to
the cellulose column (l χ 18cm) equilibrated with 5 mmol/1
Tris-HCl buffer, pH 8.3 (DEAE-cellulose) or pH 7.5 (CM-
cellulose). The columns were eluted with 30 ml of the equi-
libration buffer followed by a linear KC1 concentration gradient
(up to 0.3 mol/1) in the same buffer. Fractions of 5 ml were
collected.
Immunological procedures
We used a rabbit antiserum against homogenous arginase from
human liver, which was the A, form of arginase according to
Porembska's terminology (l 1). The antiserum was prepared and
tested s recently described (12).
Titration of arginase with antibodies was performed in mixtures
containing the enzyme preparation (0.1 —0.3 unit), MnCl2 in a
final concentration of 5 mmol/1, and appropriate dilution of
the antiserum in increasing amounts (0—50 μΐ). The samples
were adjusted to a final volume of l ml with 5 mmol/1 Tris-
HCl buffer, pH 7.5. Control samples, instead of antiserum,
contained normal rabbit serum in appropriate amounts. The
mixtures were incubated at 37 °C for 3fO min and then at 4 °C
for 18 hours to aggregate the enzyme-antibody complexes. They
were then removed by centrifugation at 25000g for 30 min,
and the residual arginase activity determined in the supernatant.
The residual fraction of arginase activity remaining in the
supernatant was expressed in relation to the units of arginase
added, which were taken s 1.00. The amounts of the antiserum
added were expressed per l unit of arginase.
Results
Bacterial contamination
The presence of the physiological bacterial flora has
no infl ence on arginase activity in saliva. Specimens
of saliva after centrifugation and incubation with 2-
mercaptoethanol at 0 °C for 2 hours were filtered
through the Millipor bacteriological filier type HA
0.45 μτη. No difference were found in arginase activity
before and after filtration.
Enzyme characteristics
Manganese dependence
Incubation at 55 °C for 20 min with a Mn2+-con-
centration of 5 mmol/1 fully activates salivary
arginase (fig. la/b). High concentrations inhibit the
enzyme. In the presence .of the same Mn2+ con-
centration, the average activity after preinc bation is
3 times higher than witho t preinc bation (tab. 1).
pH Optimum
The pH Optimum of the activated enzyme in
carbonate buffer was 9.6-9.8 (fig. 2).
Michaelis constant
The Km of the activated salivary arginase for arginine
at pH 9.8 was 4.2 ± 0.7 mmol/1 (fig. 3).
Stability on storage
Salivary arginase was more stable on storage at 0 °C
than at -10°C. At 0°C no detectable loss of the
enzyme activity was observed for at'least two days.
After one week the enzyme still retained 80% of its
initial activity. At —10 °C the enzyme was extremely
o labile, losing a fraction of about 0.50 of its initial
activity in one day (fig. 4).
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Fig. l a. Effect of manganese concentration on arginase cata-
lytic activity in saliva.
Saliva was preincubated at 55 °C for 20 min with
MnCl2 at final concentrations of l —10 mmol/1.
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Fig. Ib. Time dependence of activation with Mn2+-ions.
Saliva was preincubated for 5 — 30 min at 55 °C with
MnCl2 at a final concentration of 5 mmol/1.
Tab. l. Arginase catalytic activity in saliva of normal adults
and children (x ± l SD, r nge values in brackets).
Donors n Arginase, U/mg protein
nonactivated Μη2+-acti vated
Adults
Children
0.15
i. 0.10
σ»
.|^  0.05
<
60
8
0.06 ± 0.04
(0.01 - 0.230)
0.06 ± 0.03
(0.03 ± 0.11)
8
pH
0.17 ± 0.11
(0.02 - 0.51)
0.16 ± 0.06
(0.09 - 0.28)
10 11
Fig. 2. Relation between pH and catalytic activity of salivary
arginase.
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Fig. 3. Lineweaver-Burk plot, Substrate L-arginine.
The activity was measured in mixtures containing in-
creasing concentrations of arginine (1—40 mmol/1),
Mn2+-activated enzyme and carbonate buffer, pH 9.8.
The velocity (v) is given in μηιοΐ/min · mg protein for
ornithine s the product.
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Fig. 4. Stability of salivary arginase on storage at 0 °C (a)
(mean and ränge of 20 specimens), and — 10°C (b)'(3
different specimens).
Chromatographie properties
Ion exchange chromatography on DEAE- and CM-
cellulose revealed a single cationic form of arginase
in human normal saliva (fig. 5a/b). The enzyme was
not absorbed on DEAE cellulose at pH 8.3 and was
eluted from the column with the equilibrating buffer.
On CM-cellulose a single arginase peak was eluted
with a KC1 concentration gradient.
Immunological properties
Antiserum titrations and immunoprecipitations of
salivary arginase were carried out with rabbit anti-
serum against human liver arginase. The antiserum
also cross-reacted with arginase in the saliva of
argininaemia heterozygotes and in normal human
erythrocytes (fig. 6).
Arginase catalytic activity in saliva
Arginase activity in saliva of normal subjects
Arginase activity in the saliva of 60 normal adults
increased after activation with Mn2+ and amounted
to 0.17 ± 0.11 U/mg protein. The within assay CV
was 3.8% for a mean activity of 0.09 Ü/mg protein.
We found no significant differences in the activities
of salivary arginase of normal adults and children.
In both age groups the ränge of the enzyme activity
was wide (tab. 1).
To evaluate variations of enzyme activity in the saliva
of the same subjects, arginase was assayed in speci*
mens taken repeatedly during several days from the
same person. We found differences up to 7 the
enzyme activity in various samples from the same
donor (fig. 7).
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Fig. 5. Chromatography on DEAE-cellulose (a), and CM-
cellulose (b) of arginase from normal human saliva.
= arginase activity, = protein, -^-^— =
KC1 concentration gradient.
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Fig. 6. Antiserum titration of arginase from saliva of normal
subjects (·), argininaemia heterozygote (Q), normal
human erythrocytes (Ö).
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Fig. 7. Variation of arginase activity in saliva of the same
subject (x = mean value).
Activity of salivary arginase in argininaemia
The activity of arginase in the saliva of argininaemia
homozygotes was not detected under the assay con-
ditions used for normal saliva. Arginase activity in the
saliva of the heterozygous parents and the unaffected
daughter was within the r nge of the control group
(tab. 2).
Tab. 2. Catalytic activity of salivary arginase in a faraily with
argininaemia.
Donor Genetics Mn2+-activated
arginase
U/mg protein
Mother
Father
Healthy daughter
Affected daughters:
W.A., W.M.,W.I.
Heterozygotes
Homozygotes
0.08
0.07
0.11
0.13
not detectable
Discussion
Arginase catalyzes the last Step of the urea cycle. In
humans it is found mainly in the liver; lower catalytic
activities have been observed in erythrocytes,
leukocytes, platelets, kidney, skeleton and heart mus-
cle, brain, intestines, pancreas, hing, epidermis,
placenta, testes, plasma and fibroblasts (9). The meta-
bolic function of extrahepatic arginase is still unclear.
Arginase in saliva originales from the salivary glands.
In man it has been demonstrated in the parotid gland
(13). Its origin from serum can be excluded, because
its activity in serum (14) is up to 400 times lower
than in saliva (15). We found a pH optimum of 9.6
and a maximal manganese activation at 5 mmol/1,
compared to pH 9.3 and a Mn2+-concentration of 2
mmol/1 for the purified liver enzyme (16).
The ATm of 4.2 ± 0.7 mmol/1 is of similar magnitude
to values reported in the literature for the liver
enzyme, i.e. 2.5, 5.3 and 7.4 mmol/1 (16, 17, 18),
respectively. Our findings are in agreement with those
of Gopalakrishna & Nagarajan who reported a Mn2+
activation at 2 mmol/1, a Km of 5 mmol/1, a pH
optimum of 9.7 — 10.0 s well s storage instability
(15).
Chromatography on DEAE- and CM-cellulose
showed one peak, corresponding to the isoenzyme AI
according to Porembska, which is the major com-
ponent of human liver (0.85) and red blood cell (0.80)
arginase (11).
Antibodies against human liver arginase A! cross
reacted with the salivary enzyme. On the bases of
these findings, we postulate that salivary arginase
corresponds to the liver type Arisoenzyme. This iso-
enzyme has been demonstrated by Porembska in the
parotid gland tissue (13) and contributes chiefly to
the arginase activity of mixed saliva.
Mixed saliva can easily be collected during
unstimulated secretion. It has increasingly been used
instead of separate collection of saliva for clinical
chemical analysis of hormones, drugs and enzymes.
Arginase activity in mixed saliva has recently been
used s a parameter to evaluate the nutritional Status
ofchildren(19).
Mixed saliva was also used in our patients because
collecting samples from separate glands was impos-
sible in the three mentally retarded children with
argininaemia. However, in this case, we have ruled
out the possibility of interference from bacterial
arginase.
Arginase activity, even with complete activation, is
very low in mixed saliva. This may be related to the
low activity of arginase observed in the parotid gland
(13), which was 400 times lower than in liver tissue
and about 6 times lower than in red blood cells.
There was a large overlap between argininaemic het-
erozygotes and normal individuals. The explanation
for this remains uncertain. Since the enzyme activity
has been referred to the protein concentration,
changes in protein content in relation to the salivary
flow rate may influence the results. These changes,
however, are small under the conditions applied here,
and they would be of consequence only for a pro-
longed and intensive Stimulation of the salivary
glands (20). Whether arginase secretion is flow-de-
pendent was not examined. In view of the recent
observations with salivary amylase this is rather im-
probable at low basic secretion rates (21). The overlap
between normal individuals and heterozygotes may
therefore be attributed to biological variations.
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No activity was demonstrated in the saliva of the
argininaemia patients. Saliva can therefore be used
for rapid enzyme determination. In our opinion the
diagnosis of argininaemia, however, raust be con-
firmed by enzymatic determination in red cell pre-
parations and, if possible, in liver tissue.
The kinetic, Chromatographie and immunological
similarities of liver, red blood cell and salivary
arginase suggest their genetic identity. Its deficiency
in argininaemia provides evidence that although this
protein originates from clifferent tissues, it is under
the control of the same gene locus.
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